Slides
Page 1
Vcore pharma VICORE PHARMA Unlocking the potential of a new class of drugs – Angiotensin II type 2 receptor agonists ( ATRAGS ) September 2026
Loading workspace
Vcore pharma VICORE PHARMA Unlocking the potential of a new class of drugs – Angiotensin II type 2 receptor agonists ( ATRAGS ) September 2026
Your watchlist and earnings event details are available after you sign in.